[B cells from streptozotocin-induced mouse diabetic model inhibit insulin secretion of MIN-6 cells and promote production of insulin autoantibody].
To explore the role of B cells in the progression of mouse diabetes induced by streptozotocin (STZ). The ICR mouse diabetic model was induced by low-dose STZ injection. Radioimmunoassay was performed to examine the serum levels of insulin, and ELISA was conducted to detect insulin autoantibody (IAA). B cells from STZ-treated mice and control group were sorted by CD19 magnetic activated cell sorting (MACS), and cell purity was verified by flow cytometry. The PBS-treated MIN-6 cells were used as blank control group (group A); the isolated normal mouse B cells were incubated with MIN-6 cells as group B; B cells isolated from normal mice were pre-stimulated with 20 μg/mL lipopolysaccharides (LPS), then were incubated with MIN-6 cells, as group C; and B cells isolated from STZ-treated mice were incubated with MIN-6 cells, as group D. The mRNA and protein levels of insulin were detected by quantitative real-time PCR (qRT-PCR) and radioimmunoassay, respectively. The levels of IAA and transforming growth factor β(TGF-β) were detected by ELISA. Compared with group A, STZ-treated mice showed reduced body mass and serum insulin, but increased blood glucose and IAA levels. Flow cytometry indicated that the proportion of CD19(+) B cells were 98%. Compared with group A or B, group C or D presented with decreased mRNA and protein levels of insulin in MIN-6 cells, simultaneously, increased expressions of IAA and TGF-β. B cells isolated from STZ-treated mice promotes the production of IAA and inhibits the secretion of insulin in MIN-6 cells.